Lou Gehrig's Disease (ALS): UCSD Team's Stem Cell Therapy Rationale

Posted: June 26, 2011 at 2:38 pm



(Part 3 of 8) Don Cleveland, Ph.D. spoke at the "Spotlight on Disease Team Awards: ALS," an educational event presented at the CIRM Governing Board meeting on June 23, 2010. Goldstein is a co-principle investigator of the CIRM ALS Disease Team and member of The Ludwig Institute

Go here to see the original:
Lou Gehrig's Disease (ALS): UCSD Team's Stem Cell Therapy Rationale

Related Posts